# High Dose BAYA1040_Nifedipine: a Long Term Combination Study

> **NCT01294215** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 72 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Nifedipine (Adalat, BAYA1040)

## Key facts

- **NCT ID:** NCT01294215
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-11
- **Final completion:** 2012-06
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2014-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01294215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01294215, "High Dose BAYA1040_Nifedipine: a Long Term Combination Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01294215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*